-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
National procurement renewal: classify and implement strategies to stabilize the market and encourage innovation
Recently, the trend of renewal of national drug purchases has been higher than that of each wave.
Renew the contract and adhere to the "project system"
According to the "Opinions of the General Office of the State Council on Promoting the Normalized and Institutionalized Development of the Centralized and Volume Procurement of Drugs" (Guobanfa [2021] No.
From a comprehensive analysis point of view, the renewal products will continue to adhere to the "project system" for volume purchases, and the creation of a "project" itself contains various essential elements, from the formulation and release of bid documents, the combination of volume and price, and the guarantee of payment.
Starting from the date when the country locks the catalog, generates new prices, and expires, how to carry out a new round of mass purchase of these products is the authority of each provincial medical insurance department
From this perspective, after the contract expires, what sort of procurement measures each province will take for related varieties is, in principle, a local matter
Therefore, the national procurement renewal plan circulated in the industry in the early stage especially emphasized: "After the expiration of the national organization drug centralized procurement agreement, the province (or inter-provincial alliance) will be used as the unit to carry out the continuation work
Different landing methods
In fact, another way of thinking is, can the varieties that have already undergone national procurement be carried out on a regular basis? After all, the contract is full, the quantity has been completed, and clinical medication habits have become dependent on a certain degree of dependence.
At present, the implementation methods for renewal of nationally sourced varieties are still different in different regions: Hubei Province adopts the method of "inquiry before bidding", inquiring whether there is any new review status, and introducing unselected original research drugs at the original selected price.
An inter-provincial alliance organized by Guangdong carried out mass purchases of cephalexin, and all product specifications and dosage forms under the generic name were included
The Beijing plan is not as simple as "dual selection" as some new media claim.
Market leading
The National Procurement Renewal Plan clearly requires that, in principle, all National Procurement drugs should continue to carry out centralized and volume procurement.
It can be understood that the relevant parties do not encourage direct contract renewal.
In fact, "do not encourage" still has the shadow of classified procurement
.
The classification procurement is still carried out for the renewal products, which is actually a way to open the structure and subdivide the procurement
.
Just like the document No.
7 of Guocai, bidding and purchasing are carried out for the varieties with a large amount and the amount of money, and the bargaining of the bargaining prices of other varieties and the hanging of the net
.
The same logic is applied to the contract renewal of Guoshui.
It can be understood that the varieties selected by the equal amount due to insufficient competition at the time can be understood as belonging to the price reduction and there is still room for price reduction.
Under the new situation, it is understandable to use multiple competitions to bid for such varieties
.
For varieties with relatively sufficient competition, especially 6 and above, they can only be listed as "competitive varieties".
There is still a certain distance from the "sufficient competition".
It can be seen that under the new situation, the concept of sufficient competition has There are new changes
.
Based on this, on the basis of stabilizing prices, relevant parties are still inclined to comprehensive reviews
.
At the same time, it is particularly mentioned that if the price in the last round was low and the cost cannot continue to be supplied, the price can rise appropriately.
This is more like a rational market behavior.
The price has indeed bottomed out and a callback can be allowed
.
After all, in market competition, no one wants to see ultra-low prices without reasonable profits
.
Judging from a series of local operations in the renewal of the national procurement, the classification of policies, one category and one policy is still the overall guiding principle of the national procurement renewal varieties.
Some prices must be "stable", and some prices are allowed to be moderately increased.
Others have low prices or high prices
.
In short, the price competition method under the classification model is still dominated by the current market situation.
If the market has a positive effect, it will continue to advance.
If the market has a certain negative impact, it is necessary to stop the loss in time
.
Reflected in the price of volume purchases, that's it
.
This content is the original creation of the "Pharmaceutical Economic News" financial media platform
.
Without the authorization of "Pharmaceutical Economic News", it may not be used in any way, including reprinting, extracting, copying, or creating mirror images
.
If you need authorization, please contact: 020-37886610 or 020-37886753; yyjjb@21cn.
com
.